Liselotte Onelöv

1.1k total citations
15 papers, 851 citations indexed

About

Liselotte Onelöv is a scholar working on Cardiology and Cardiovascular Medicine, Hematology and Otorhinolaryngology. According to data from OpenAlex, Liselotte Onelöv has authored 15 papers receiving a total of 851 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 4 papers in Hematology and 3 papers in Otorhinolaryngology. Recurrent topics in Liselotte Onelöv's work include Atrial Fibrillation Management and Outcomes (5 papers), Cardiac Arrhythmias and Treatments (3 papers) and Head and Neck Cancer Studies (3 papers). Liselotte Onelöv is often cited by papers focused on Atrial Fibrillation Management and Outcomes (5 papers), Cardiac Arrhythmias and Treatments (3 papers) and Head and Neck Cancer Studies (3 papers). Liselotte Onelöv collaborates with scholars based in Sweden, Slovenia and Canada. Liselotte Onelöv's co-authors include Tina Dalianis, Hanna Dahlstrand, Lalle Hammarstedt‐Nordenvall, Weimin Ye, David Lindquist, Eva Munck‐Wikland, Mircea Romanitan, Johan Lindholm, Jeanna Joneberg and Anders Näsman and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Scientific Reports.

In The Last Decade

Liselotte Onelöv

14 papers receiving 830 citations

Peers

Countries citing papers authored by Liselotte Onelöv

Since Specialization

Citations

This map shows the geographic impact of Liselotte Onelöv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liselotte Onelöv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liselotte Onelöv more than expected).

Fields of papers citing papers by Liselotte Onelöv

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liselotte Onelöv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liselotte Onelöv. The network helps show where Liselotte Onelöv may publish in the future.

Co-authorship network of co-authors of Liselotte Onelöv

This figure shows the co-authorship network connecting the top 25 collaborators of Liselotte Onelöv. A scholar is included among the top collaborators of Liselotte Onelöv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liselotte Onelöv. Liselotte Onelöv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Evaluation of the MRX PT DOAC assay for detection of clinically relevant factor Xa inhibitor drug levels 2024 ·Journal of Thrombosis and Haemostasis ·Brittany Salter, Karen A. Moffat, (unknown), (unknown), Laurel Beckett, (unknown), Liselotte Onelöv, (unknown), (unknown), (unknown), (unknown), Steven Kitchen, Mark Crowther, Siraj Mithoowani	0
2	Clot time ratio (CTR) and treatment outcomes in Apixaban-treated atrial fibrillation patients 2024 ·Scientific Reports ·Liselotte Onelöv, Mojca Božič Mijovski, Alenka Mavri	1
3	Clot time ratio (CTR) and relation to treatment outcome in patients with atrial fibrillation treated with Rivaroxaban 2024 ·Thrombosis Journal ·Liselotte Onelöv, Elvar Theodorsson, Mojca Božič Mijovski, Alenka Mavri	1
4	Predictive Ability of a Clinical-Genetic Risk Score for Venous Thromboembolism in Northern and Southern European Populations 2021 ·SHILAP Revista de lepidopterología ·Eduardo Salas, (unknown), Sara Pich, Liselotte Onelöv, Kévin Guillen, (unknown), Jovan P. Antović, José Manuel Soria	4
5	Genetics and Hemostatic Potential in Persons with Mild to Moderate Hemophilia A with a Discrepancy between One-Stage and Chromogenic FVIII Assays 2020 ·Thrombosis and Haemostasis ·Annelie Strålfors, Danijela Miković, David E. Schmidt, Liselotte Onelöv, (unknown), (unknown), Roza Chaireti, Margareta Holmström, Jovan P. Antović, Maria Bruzelius	6
6	Age‐adjusted D‐dimer cut‐off leads to more efficient diagnosis of venous thromboembolism in the emergency department: a comparison of four assays 2018 ·Journal of Thrombosis and Haemostasis ·(unknown), Anwar J. Siddiqui, Liselotte Onelöv, (unknown), (unknown), (unknown), Anders Kallner, Margareta Holmström, Jovan P. Antović	24
7	Hepcidin levels correlate to liver iron content, but not steatohepatitis, in non-alcoholic fatty liver disease 2018 ·BMC Gastroenterology ·(unknown), Soheir Beshara, Gösta Eggertsen, Liselotte Onelöv, Nils Albiin, Olof Danielsson, Rolf Hultcrantz, Per Stål	33
8	Autoverification of routine coagulation assays in a multi-center laboratory 2016 ·Scandinavian Journal of Clinical and Laboratory Investigation ·Liselotte Onelöv, (unknown), (unknown), Helena Andersson, (unknown), (unknown), (unknown), (unknown), Jovan P. Antović	16
9	Age-Adjusted D-Dimer Cutoffs for DVT and Pulmonary Embolism: A Comparison of Five Assays 2016 ·Blood ·(unknown), Anwar J. Siddiqui, Liselotte Onelöv, Roza Chaireti, Margareta Holmström, Jovan P. Antović	5
10	Evaluation of small‐volume tubes for venous and capillary PT (INR) samples 2015 ·International Journal of Laboratory Hematology ·Liselotte Onelöv, (unknown), Anders Svensson, Magnus Nilsson, Jovan P. Antović	6
11	Validation of a competitive ELISA assay for the quantification of human serum hepcidin. 2015 ·PubMed ·Gunilla Dahlfors, Per Stål, (unknown), Peter Bárány, Christin Sisowath, Liselotte Onelöv, (unknown), Gösta Eggertsen, (unknown), Soheir Beshara	16
12	Evaluation of coagulation assays versus LC-MS/MS for determinations of dabigatran concentrations in plasma 2013 ·European Journal of Clinical Pharmacology ·Jovan P. Antović, Mika Skeppholm, (unknown), (unknown), (unknown), (unknown), Liselotte Onelöv, Yuko Rönquist-Nii, Anton Pohanka, Olof Beck, Paul Hjemdahl, Rickard E. Malmström	91
13	The incidence of tonsillar cancer in Sweden is increasing 2007 ·Acta Oto-Laryngologica ·Lalle Hammarstedt‐Nordenvall, Hanna Dahlstrand, David Lindquist, Liselotte Onelöv, Michael Ryott, Juhua Luo, Tina Dalianis, Weimin Ye, Eva Munck‐Wikland	119
14	Human papillomavirus is a favourable prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7 2007 ·Molecular Oncology ·David Lindquist, Mircea Romanitan, Lalle Hammarstedt‐Nordenvall, Anders Näsman, Hanna Dahlstrand, Johan Lindholm, Liselotte Onelöv, Torbjörn Ramqvist, Weimin Ye, Eva Munck‐Wikland, Tina Dalianis	165
15	Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer 2006 ·International Journal of Cancer ·Lalle Hammarstedt‐Nordenvall, David Lindquist, Hanna Dahlstrand, Mircea Romanitan, Liselotte Onelöv, Jeanna Joneberg, (unknown), Johan Lindholm, Weimin Ye, Tina Dalianis, Eva Munck‐Wikland	364

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact